Ultragenyx Pharmaceutical Inc. (RARE) Earnings
NASDAQ·Healthcare·Biotechnology
$27.67
+11.33%
Mkt Cap $2.26B
EPS — Estimate vs Actual
Mkt Cap
$2.26B
P/E
—
Fwd P/E
—
P/S
3.38
Rev TTM
—
EPS TTM
-$6.11
NASDAQ·Healthcare·Biotechnology
$27.67
+11.33%
Mkt Cap $2.26B
Mkt Cap
$2.26B
P/E
—
Fwd P/E
—
P/S
3.38
Rev TTM
—
EPS TTM
-$6.11